Surprise finding could lead to new MS treatments

March 8, 2018 by Ross Neitz, University of Alberta
Biochemistry professor Marek Michalak is part of a research team that was surprised to discover unusually high levels of a protein called calnexin in brain tissue from people who had MS—a finding that could lead to new ways of treating the debilitating disease. Credit: University of Alberta

A surprise finding by medical scientists may lead to the development of a possible treatment for multiple sclerosis (MS).

While examining human brain tissues, researchers from the University of Alberta and McGill University unexpectedly found that the tissues from people who had MS contained an extremely high level of a protein named calnexin, compared with those who hadn't had MS.

The researchers then tested the susceptibility of mice lacking calnexin to the mouse model of human MS (experimental autoimmune encephalomyelitis), and were astonished to find that the mice lacking the protein were completely resistant to the disease.

The causes of MS are not well understood. Symptoms vary widely but often include cognitive impairment, dizziness, tremors and fatigue. These problems are caused by a type of called T cells that, after becoming activated, find their way into the brain and attack the protective covering—myelin—of neurons in the brain and spinal cord, causing inflammation and damage to the central nervous system.

"It turns out that calnexin is somehow involved in controlling the function of the blood-brain barrier," said Marek Michalak, a distinguished professor of biochemistry at the U of A. "This structure usually acts like a wall and restricts the passage of cells and substances from the blood into the brain. When there is too much calnexin, this wall gives angry T cells access to the , where they destroy myelin."

Canada has one of the highest rates of MS in the world, with an estimated one in 340 Canadians living with the disease. There are no known effective treatments.

"We think this exciting finding identifies calnexin as an important target for developing therapies for MS," said Luis Agellon, a professor at the McGill School of Human Nutrition. "Our challenge now is to tease out exactly how this protein works in the involved in making up the . If we knew exactly what calnexin does in this process, then we could find a way to manipulate its function to promote resistance for developing MS."

Explore further: Potential new approach to the treatment of multiple sclerosis

More information: Joanna Jung et al. Calnexin is necessary for T cell transmigration into the central nervous system, JCI Insight (2018). DOI: 10.1172/jci.insight.98410

Related Stories

Potential new approach to the treatment of multiple sclerosis

March 5, 2018
A prospective new method of treating patients with multiple sclerosis has been proposed by researchers of the Mainz University Medical Center working in cooperation with researchers of the University of Montreal. In model ...

How rogue immune cells cross the blood-brain barrier to cause multiple sclerosis

November 21, 2017
Drug designers working on therapeutics against multiple sclerosis should focus on blocking two distinct ways rogue immune cells attack healthy neurons, according to a new study in the journal Cell Reports.

ALS-linked protein's journey into nervous system cells more complex than we thought

February 28, 2018
University of Bath scientists have developed a better understanding of a key protein associated with brain diseases including ALS (motor neurone disease) and dementia by studying how it enters central nervous system cells.

Faults in the blood-brain barrier implicated in dementia

February 6, 2018
California based researchers have found that damage to cells known as pericytes, which surround small blood vessels in the brain, may trigger a chain of events that results in brain degeneration. The findings are published ...

Researchers report novel complementary effects of estrogen treatment in multiple sclerosis

December 28, 2017
A study by UCLA researchers reveals the cellular basis for how the hormone estrogen protects against damage to the central nervous system in people with multiple sclerosis (MS). The researchers found that estrogen treatment ...

Identifying the dangers of chronic stress on multiple sclerosis

February 6, 2018
New research reveals how chronic stress and tiny brain inflammations cause fatal gut failure in a multiple sclerosis mouse model.

Recommended for you

Sensitive babies become altruistic toddlers

September 25, 2018
Our responsiveness to seeing others in distress accounts for variability in helping behavior from early in development, according to a study published September 25 in the open-access journal PLOS Biology by Tobias Grossmann ...

Immune cell pruning of dopamine receptors may modulate behavioral changes in adolescence

September 25, 2018
A study by MassGeneral Hospital for Children (MGHfC) researchers finds that the immune cells of the brain called microglia play a crucial role in brain development during adolescence, but that role is different in males and ...

Scientists reverse a sensory impairment in mice with autism

September 25, 2018
Using a genetic technique that allows certain neurons in the brain to be switched on or off, UCLA scientists reversed a sensory impairment in mice with symptoms of autism, enabling them to learn a sensory task as quickly ...

Why it doesn't get dark when you blink

September 25, 2018
People blink every five seconds. During this brief moment, no light falls on the retina, yet people continue to observe a stable picture of the environment with no intervals of darkness. Caspar Schwiedrzik and Sandrin Sudmann, ...

Lung inflammation from childhood asthma linked with later anxiety

September 25, 2018
Persistent lung inflammation may be one possible explanation for why having asthma during childhood increases your risk for developing anxiety later in life, according to Penn State researchers.

Researchers identify new cause of brain bleeds

September 25, 2018
A team of researchers including UCI project scientist Rachita Sumbria, Ph.D. and UCI neurologist Mark J. Fisher, MD have provided, for the first time, evidence that blood deposits in the brain may not require a blood vessel ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.